ABSTRACT
BACKGROUND: The impact of COVID-19 in families and patients with congenital diaphragmatic hernia (CDH) is unknown, this situation has generated uncertainty not only in family members but also in the optimal outpatient follow-up. Telehealth has become a fundamental tool for the follow-up during the pandemic. The objective of this survey is to evaluated the impact of SARS-CoV-2 in families and patients with CDH and the satisfaction with telematic follow-up. METHODS: Telephone survey of patient's caregivers with CHD, aged 1-16 years, followed in neonatal surgery outpatients, from January 31, 2020 to November 15, 2020. The ethical clearance for this study was taken from the Clinical Research Ethics Committee of our Research Institute vide letter number VHIR/239283/01.01.2021. RESULTS: 81 surveys of 100 patients with active follow-up were carried out. There were no refusals in any contacted parents. There were 30 contacts (37%), 44.8% at school and 27.6% from cohabiting family members. Four infections (4.9%) were diagnosed, half symptomatic. In 40 patients (49.4%) the follow-up was telematic, with a mean score of 3.1±1.3 out of 5. For future controls, 65% prefer presential follow-up, 25% alternate and 10% telematics. 50.6% reported greater anxiety and 34.6% (28/81) extreme measures of isolation, being more accentuated in the group of 3-6 years (p<0.05). CONCLUSION: The impact of COVID19 in patients with CHD is not greater than in the general pediatric population. Although the incorporation of the telehealth was well valued, most of the caregivers prefer the face-to-face outpatient follow-up.
ABSTRACT
Introduction & Objective: Urologic-related visits to the emergency department (ED) are variable in their acuity, ranging from non-emergent to life-threatening. We sought to evaluate trends in urologic presentations to the ED during the COVID-19 pandemic at a tertiary academic institution in the United States to determine the differences in frequency between urgent and nonurgent visits and further elucidate delayed access to urologic care. Methods: A retrospective analysis was performed comparing the frequency and type of urologic-related ED visits at our institution in January-April 2019 to those in January-April 2020 during the initial pandemic phase. 1,838 urologic presentations between the two-time intervals were organized by diagnosis and divided by acuity into urgent and non-urgent categories. Interrupted time series regression models were used to determine how urologicrelated ED visits changed due to the COVID-19 pandemic. Results: The total number of urologic related ED visits by type for each time interval is demonstrated in Table 1. There was a statistically significant drop in total urologic-related ED visits after the COVID-19 pandemic began, with a drop in total visits of approximately 76 per month (p = 0.002). There was no difference in the number of urgent ED visits due to the COVID-19 pandemic (p = 0.13). However, there was a statistically significant decrease in non-urgent ED visits, with a decrease of 68 visits per month (p = 0.002). When examining the individual visit types, there were no differences in visit volume except for hematuria and nephrolithiasis/ureterolithiasis visits. There was a statistically significant reduction in hematuria-related ED visits, with a reduction in visits of approximately 11 per month (p = 0.03). Similarly, there was a statistically significant decline in nephrolithiasis/ ureterolithiasis-related ED visits, with a decline of approximately 28 visits per month (p = 0.04). Conclusions: The COVID-19 pandemic coincided with a significant decrease in the number of non-urgent urologic presentations to our institution's ED. Specifically, there was a significant decrease in the number of patients presenting with hematuria and nephrolithiasis-related issues. There was no significant decrease in the number of urgent urologic consults. Follow up study is indicated to investigate the effect of delayed evaluation for these non-urgent urologic diagnoses. (Table Presented).